| Primary |
| Fabry's Disease |
50.2% |
| Product Used For Unknown Indication |
34.5% |
| Premedication |
4.9% |
| Drug Use For Unknown Indication |
3.2% |
| Pain |
1.4% |
| Hypertension |
0.8% |
| Renal Transplant |
0.7% |
| Cardiac Disorder |
0.7% |
| Prophylaxis |
0.6% |
| Depression |
0.3% |
| Anxiety |
0.3% |
| Anaemia |
0.3% |
| Diabetes Mellitus |
0.3% |
| Gastrooesophageal Reflux Disease |
0.3% |
| Prophylaxis Against Transplant Rejection |
0.3% |
| Renal Failure |
0.2% |
| Anticoagulant Therapy |
0.2% |
| Drug Therapy |
0.2% |
| Neuralgia |
0.2% |
| Renal Failure Chronic |
0.2% |
|
| Vomiting |
9.0% |
| Renal Failure |
8.6% |
| Death |
8.1% |
| Transient Ischaemic Attack |
6.6% |
| Renal Transplant |
6.3% |
| Pyrexia |
6.2% |
| Renal Failure Chronic |
6.0% |
| Myocardial Infarction |
5.7% |
| Tremor |
5.0% |
| Cerebrovascular Accident |
4.6% |
| Renal Disorder |
4.4% |
| Renal Impairment |
4.3% |
| Ventricular Tachycardia |
3.4% |
| Cardiac Disorder |
3.3% |
| Weight Decreased |
3.3% |
| Cardiac Failure |
3.2% |
| Pain |
3.2% |
| Urticaria |
3.2% |
| Tachycardia |
2.9% |
| Wheezing |
2.9% |
|
| Secondary |
| Fabry's Disease |
42.7% |
| Product Used For Unknown Indication |
33.7% |
| Drug Use For Unknown Indication |
5.7% |
| Premedication |
5.7% |
| Pain |
1.6% |
| Prophylaxis |
1.5% |
| Renal Transplant |
1.3% |
| Hypertension |
1.2% |
| Prophylaxis Against Transplant Rejection |
1.0% |
| Cardiac Disorder |
0.7% |
| Renal Failure |
0.7% |
| Renal Failure Chronic |
0.6% |
| Anaemia |
0.5% |
| Chest Pain |
0.5% |
| Vitamin Supplementation |
0.5% |
| Cardiac Failure |
0.5% |
| Drug Therapy |
0.5% |
| Anxiety |
0.4% |
| Depression |
0.4% |
| Heart Valve Replacement |
0.4% |
|
| Vomiting |
10.2% |
| Renal Disorder |
8.0% |
| Weight Decreased |
6.7% |
| Transient Ischaemic Attack |
6.4% |
| Renal Failure Chronic |
6.2% |
| Renal Failure |
5.9% |
| Deafness Unilateral |
5.4% |
| Osteomyelitis |
5.4% |
| Renal Impairment |
5.4% |
| Pain |
5.1% |
| Weight Increased |
5.1% |
| Pyrexia |
4.0% |
| Urinary Tract Infection |
3.8% |
| Adverse Event |
3.5% |
| Arteriosclerosis Coronary Artery |
3.2% |
| Myocardial Infarction |
3.2% |
| Paraesthesia |
3.2% |
| Ventricular Tachycardia |
3.2% |
| Wheezing |
3.2% |
| Arrhythmia |
2.9% |
|
| Concomitant |
| Drug Use For Unknown Indication |
33.3% |
| Fabry's Disease |
20.0% |
| Neuropathy Peripheral |
10.0% |
| Premedication |
6.7% |
| Anaemia |
3.3% |
| Convulsion |
3.3% |
| Migraine |
3.3% |
| Migraine Prophylaxis |
3.3% |
| Multi-vitamin Deficiency |
3.3% |
| Multiple Sclerosis |
3.3% |
| Seasonal Allergy |
3.3% |
| Swelling |
3.3% |
| Thrombosis Prophylaxis |
3.3% |
|
| Infusion Related Reaction |
25.0% |
| Vomiting |
25.0% |
| Intracardiac Thrombus |
12.5% |
| Pyrexia |
12.5% |
| Somnolence |
12.5% |
| Visual Acuity Reduced |
12.5% |
|
